Want to join the conversation?
$ACM said during 3Q16, in the UK, revenue grew by 6.3% and backlog was solid with continued demand to maintain and modernize infrastructure assets. The Brexit referendum has created some uncertainty and the full impact to the market and the company's business remains unclear. In the Middle East, $ACM saw strong profitability.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.